MX174433B - Proceso para preparar 3-arilcarbonil-1h-indol y producto obtenido - Google Patents

Proceso para preparar 3-arilcarbonil-1h-indol y producto obtenido

Info

Publication number
MX174433B
MX174433B MX024839A MX2483991A MX174433B MX 174433 B MX174433 B MX 174433B MX 024839 A MX024839 A MX 024839A MX 2483991 A MX2483991 A MX 2483991A MX 174433 B MX174433 B MX 174433B
Authority
MX
Mexico
Prior art keywords
indol
prepare
product obtained
aryl carbonyl
indoles
Prior art date
Application number
MX024839A
Other languages
English (en)
Other versions
MX24839A (es
Inventor
Susan Jean Ward
Malcolm Rice Bell
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of MX24839A publication Critical patent/MX24839A/es
Publication of MX174433B publication Critical patent/MX174433B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un compuesto que tiene la fórmula: caracterizado porque R2 es hidrógeno o alquilo inferior; y R3 es alcoximetilfenilo inferior, bencilo, alcoxiestiril inferior, (1H-imidazol-1-il)naftil, 2-(1-naftil)etenil, 1-(1,2,3,4-tetra-hidronaftil), antrilo, fenantrilo o pirenilo; y sales de adición ácida del mismo.
MX024839A 1990-03-08 1991-03-08 Proceso para preparar 3-arilcarbonil-1h-indol y producto obtenido MX174433B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49020190A 1990-03-08 1990-03-08

Publications (2)

Publication Number Publication Date
MX24839A MX24839A (es) 1993-10-01
MX174433B true MX174433B (es) 1994-05-16

Family

ID=23947024

Family Applications (1)

Application Number Title Priority Date Filing Date
MX024839A MX174433B (es) 1990-03-08 1991-03-08 Proceso para preparar 3-arilcarbonil-1h-indol y producto obtenido

Country Status (21)

Country Link
EP (1) EP0445781B1 (es)
JP (1) JP3157179B2 (es)
KR (1) KR0183396B1 (es)
AT (1) ATE133663T1 (es)
AU (1) AU643757B2 (es)
CA (1) CA2036307C (es)
DE (1) DE69116705T2 (es)
DK (1) DK0445781T3 (es)
ES (1) ES2082872T3 (es)
FI (1) FI95369C (es)
GR (1) GR3019058T3 (es)
HU (1) HU215125B (es)
IE (1) IE72953B1 (es)
IL (1) IL97426A (es)
MX (1) MX174433B (es)
MY (1) MY106109A (es)
NO (1) NO179612C (es)
NZ (1) NZ237309A (es)
PH (1) PH27022A (es)
PT (1) PT96938B (es)
RU (1) RU2073670C1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
FR2713224B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
ES2099007B1 (es) * 1993-07-16 1997-12-01 Pfizer Res & Dev Derivados de indol.
FR2714057B1 (fr) * 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DE69921314T2 (de) * 1998-05-01 2006-02-09 Eli Lilly And Co., Indianapolis INHIBITORISCHE ESTER FÜR sPLA 2
PT985414E (pt) * 1998-05-26 2004-01-30 Pfizer Prod Inc Metodo de tratamento de glaucoma e retinopatia isquemica
WO2001040183A1 (en) * 1999-12-03 2001-06-07 Alcon Universal Ltd. 1-aminoalkyl-1h-indoles for treating glaucoma
ATE409491T1 (de) * 2000-01-18 2008-10-15 Merck & Co Inc Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension
CA2399791A1 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
SE0203070D0 (en) * 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds
TW200508197A (en) * 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
FR2893615B1 (fr) * 2005-11-18 2008-03-07 Sanofi Aventis Sa Derives de 3-acylindole, leur preparation et leur application en therapeutique
KR101723125B1 (ko) 2015-07-29 2017-04-04 이은솔 개선된 구조의 위생 젓가락
JP6025234B1 (ja) * 2016-03-10 2016-11-16 株式会社サンライフ 箸における箸置き形成方法及び箸置き機能を有する箸
CN107628981B (zh) * 2017-10-31 2019-07-30 威海市妇女儿童医院 一种肉桂酰基吲哚啉化合物及其制备青光眼药物的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
US4581354A (en) * 1984-08-06 1986-04-08 Sterling Drug Inc. 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles, compositions and use
US4634776A (en) * 1984-08-06 1987-01-06 Sterling Drug, Inc. 3-arylcarbonyl-and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles
US4634698A (en) * 1984-09-24 1987-01-06 Schering Corporation Antiglaucoma agents
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
KR910016745A (ko) 1991-11-05
PH27022A (en) 1993-02-01
HU215125B (hu) 1998-09-28
NZ237309A (en) 1993-02-25
HUT56492A (en) 1991-09-30
ES2082872T3 (es) 1996-04-01
GR3019058T3 (en) 1996-05-31
CA2036307A1 (en) 1991-09-09
EP0445781A1 (en) 1991-09-11
MY106109A (en) 1995-03-31
FI911131A (fi) 1991-09-09
AU7266991A (en) 1991-09-12
NO910868D0 (no) 1991-03-05
DE69116705D1 (de) 1996-03-14
FI911131A0 (fi) 1991-03-06
PT96938B (pt) 1998-07-31
DE69116705T2 (de) 1996-09-26
JP3157179B2 (ja) 2001-04-16
IE910700A1 (en) 1991-09-11
IE72953B1 (en) 1997-05-07
JPH04235164A (ja) 1992-08-24
MX24839A (es) 1993-10-01
AU643757B2 (en) 1993-11-25
DK0445781T3 (da) 1996-02-19
FI95369C (fi) 1996-01-25
IL97426A (en) 1996-03-31
KR0183396B1 (ko) 1999-05-01
NO179612B (no) 1996-08-05
CA2036307C (en) 2002-07-09
FI95369B (fi) 1995-10-13
NO910868L (no) 1991-09-09
ATE133663T1 (de) 1996-02-15
IL97426A0 (en) 1992-06-21
PT96938A (pt) 1991-10-31
EP0445781B1 (en) 1996-01-31
RU2073670C1 (ru) 1997-02-20
NO179612C (no) 1996-11-13

Similar Documents

Publication Publication Date Title
MX174433B (es) Proceso para preparar 3-arilcarbonil-1h-indol y producto obtenido
ATE103914T1 (de) Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen.
DK0490823T3 (es)
BR9300707A (pt) Composicao para o tratamento dos cabelos e processo de condicionamento dos cabelos
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
HU901325D0 (en) Process for preparation of 4-phenyl-1,2,3,4-tetrahydro-1-naphthaleneamine derivatives
PL289487A1 (en) Method of producing new aminophenol derivatives
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
DK0472327T3 (da) Præparat på form af øjendråber
DE59108945D1 (de) Werkstoff und verfahren zu seiner herstellung
ES2169037T3 (es) Conjugados polietilenglicol-hirudina, su procedimiento de preparacion y su empleo para el tratamiento de las trombosis.
DK0443848T3 (da) Nyt antiulcermiddel
AU1413788A (en) Dihydropyridinamides process for their preparation, and their use in medicaments
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
MX9303515A (es) Procedimiento de preparacion de un producto amilaceo ceroso estable y producto obtenido.
HUT45007A (en) Pesticide compositions containing n-(/2-cyano-2-oximino/-acetyl)-aminonitril derivatives as active components and process for producing the active components
HU904667D0 (en) Process for producing s-substituted thioacrryl-amides
DE69116216D1 (de) Verwendung von Squalene, Squalane oder deren Mischungen zur Herstellung einer abkühlenden Zusammensetzung zur örtlichen Behandlung von Verbrennungen
HUT44132A (en) Herbicide compositions containing pyrazolo-(-3,4-b-)-pyridine derivatives as active components and process for producing the active components
HU913540D0 (en) Process for the protection of plant cultivation by using triazolyl- or imidazolyl-methyl-allyl-alcoholes, and the new compounds used in the process
BR9005102A (pt) Processo para fazer n,n,n',n'-tetra-alcoxi-metil-ciclo-hexano-carboguanaminas,produtos obtidos,e composicao de cura rapida
HUT56069A (en) Fungicide composition sontaining pyridyl-cyclopropane-amines as active components and process for producing the active components
ATE6124T1 (de) Arzneimittel zur lokalen behandlung des glaukoms.
IL83083A0 (en) Pyran derivatives,their production and their use as pesticides
ATE192336T1 (de) Verwendung von bifemelan zur herstellung eines arzneimittels zur behandlung der hyperkinesie